CRIS Current Research Information System

BRODOSI, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.389
NA - Nord America 3.638
EU - Europa 2.203
SA - Sud America 212
AF - Africa 209
OC - Oceania 2
Totale 10.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.557
SG - Singapore 1.185
CN - Cina 1.059
VN - Vietnam 947
IT - Italia 561
HK - Hong Kong 368
GB - Regno Unito 326
DE - Germania 283
SE - Svezia 248
IN - India 204
FR - Francia 179
KR - Corea 167
BR - Brasile 154
NL - Olanda 126
BD - Bangladesh 115
FI - Finlandia 99
IE - Irlanda 89
RU - Federazione Russa 86
JP - Giappone 78
ZA - Sudafrica 53
CA - Canada 48
CI - Costa d'Avorio 43
SC - Seychelles 43
PH - Filippine 38
BG - Bulgaria 35
ID - Indonesia 34
UA - Ucraina 28
JO - Giordania 27
NG - Nigeria 25
TH - Thailandia 23
TR - Turchia 23
AT - Austria 21
PK - Pakistan 21
PL - Polonia 21
CH - Svizzera 20
AR - Argentina 19
TG - Togo 19
GR - Grecia 18
MX - Messico 18
IQ - Iraq 17
BE - Belgio 15
SA - Arabia Saudita 14
MY - Malesia 13
TW - Taiwan 13
ES - Italia 11
IR - Iran 11
EC - Ecuador 10
EE - Estonia 9
LT - Lituania 9
EG - Egitto 8
CO - Colombia 7
CL - Cile 6
PE - Perù 6
RO - Romania 6
YE - Yemen 6
NP - Nepal 5
AZ - Azerbaigian 4
CR - Costa Rica 4
LB - Libano 4
PY - Paraguay 4
AO - Angola 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LY - Libia 2
MA - Marocco 2
NO - Norvegia 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 10.653
Salva come PNG Salva come JPEG
Città #
Singapore 828
Ashburn 499
Hong Kong 348
Hefei 345
Southend 240
Chandler 233
Hanoi 220
San Jose 216
Ho Chi Minh City 214
Santa Clara 190
Seoul 151
Fairfield 150
Dallas 138
Bologna 135
Los Angeles 112
Beijing 109
Princeton 97
Boardman 96
Seattle 91
Dublin 89
Helsinki 84
Houston 81
Council Bluffs 77
Woodbridge 76
Lauterbourg 65
Dong Ket 63
New York 60
Wilmington 59
Tokyo 56
Redmond 53
Ann Arbor 49
Cambridge 49
Milan 45
Abidjan 43
Bengaluru 40
Rome 38
Johannesburg 36
Buffalo 34
Munich 34
Sofia 34
Frankfurt am Main 33
São Paulo 32
Da Nang 31
Redondo Beach 31
Haiphong 29
Guangzhou 28
Abeokuta 25
Amman 25
Des Moines 25
Berlin 24
Turin 24
Medford 23
Shanghai 23
San Diego 22
London 21
Clifton 20
Lomé 19
Montreal 17
Westminster 17
Jakarta 16
Amsterdam 15
Brussels 15
Phoenix 15
Piscataway 15
Atlanta 14
Warsaw 14
Brooklyn 13
Falkenstein 13
Jinan 13
Orem 13
Padova 13
Paris 13
Chicago 12
Düsseldorf 12
Kuala Lumpur 12
Lappeenranta 12
Parma 12
San Francisco 12
Tongling 12
Dhaka 11
Hyderabad 11
Hải Dương 11
Nanjing 11
Naples 11
Nuremberg 11
Rimini 11
Vienna 11
Zhengzhou 11
Biên Hòa 10
Denver 10
Florence 10
Jacksonville 10
North Bergen 10
Bangkok 9
Bern 9
Chennai 9
Istanbul 9
Mexico City 9
Saint Petersburg 9
Wuhan 9
Totale 6.524
Salva come PNG Salva come JPEG
Nome #
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers 272
Liver Stiffness measurments using Fibroscan after three months of IFN-based antiviral therapy is unlikely to predict viral response in cirrhotic patients. 246
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study 242
Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential 229
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 227
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 222
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 222
Management of non-alcoholic fatty liver disease 218
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 211
Long-term weight loss maintenance for obesity: A multidisciplinary approach 211
Eating habits in patients affected by metabolic syndrome and liver disease (hepatitis, cirrhosis and liver transplant) 206
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting 200
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 199
Pegvaliase therapy for phenylketonuria: Real-world case series and clinical insights 194
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease 192
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report. 190
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. 189
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs 177
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 176
Lifestyle changes for the treatment of nonalcoholic fatty liver disease-a 2015-19 update 175
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 168
Dati preliminari sullo studio della sintomatologia ortoressica tra pazienti diabetici affetti da epatopatia. 166
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease 164
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink? 163
CD 133+ stem cells for the treatment of end stage liver disease. 162
Fatty liver in pregnancy: a narrative review of two distinct conditions 159
A cross-sectional study on the prevalence of eating disorders in liver transplanted patients with type 2 diabetes and/or overweight/obesity 156
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity 155
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. 152
Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey 151
Maternal PKU: Defining phenylalanine tolerance and its variation during pregnancy, according to genetic background 148
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 147
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. 144
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 144
Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction 142
Malnutrition in hospitalized patients with SARS-CoV-2 infection 137
Obesity and NAFLD: Same problem? 132
The treatment of diabetes in advanced liver disease: change of a paradigm 129
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome 128
Bone marrow derived stem cells for the treatment of end-stage liver disease. 125
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 125
COMBINATION study: COMbined Behavioural/INcretin Action sTudy In Obese/diabetic persoNs 124
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis. 120
NEUROD1 mutation in an Italian patient with maturity onset diabetes of the young 6: a case report 118
Effect of physical exercise on postural control in diabetic subjects 117
Psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects 115
NASH: A glance at the landscape of pharmacological treatment 114
Capitolo 14 "Epatiti Virali Croniche", Volume IX "Malattie del Fegato, delle Vie Biliari e del Pancreas", Trattato di Medicina Interna, fondato da Paolo Larizza 113
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease 113
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 110
CD133+ hematopoietic stem cells reinfusion in end-stage liver disease (ESLD): final results of a phase I clinical trial 106
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients 106
CD133+ stem cells for the treatment of end-stage liver disease 105
The management of transitional care of patients affected by phenylketonuria in Italy: Review and expert opinion 104
Relationship Between Physical Activity and Autonomic Responses in Adults with Type 2 Diabetes 98
'Effect of exercise training on postural control in people with diabetes 97
Exercise-induced changes in postural stability among patients with diabetes 97
Effects of physical exercise on autonomic control in diabetic patients. 96
Web-based counseling for NAFLD. Final results. 96
Undiagnosed Phenylketonuria Can Exist Everywhere: Results From an International Survey 95
Impact of exercise training on postural control in people with diabetes. 91
Reinfusion of highly purified CD133+ stem cells in patients with end-stage liver disease (ESLD): final results of a phase I clinical trial 88
Management of patients with phenylketonuria (PKU) under enzyme replacement therapy: An Italian model (expert opinion) 87
Effects of Physical Activity Level on Microsaccade Dynamics During Optic Flow Stimulation in Adults with Type 2 Diabetes 79
Benefits of a prolonged-release amino acid mixture in four pregnant women with phenylketonuria 76
Effect of six months of exercise program on eye movements of diabetic people. 68
Increased survival after sustained virological response in liver transplanted patients with HCV recurrence: taking-up a challenge for the hepatologist. 68
Increased survival after sustained virological response in liver transplanted patients with HCV recurrence: taking-up a challenge for the hepatologist. 68
NAFLD, the hepatic manifestation of the metabolic syndrome 68
Night eating syndrome in liver transplant recipients with diabetes or excess-weight: a cross-sectional study 66
Hepatitis C recurrence after liver transplantation: do patients with mild disease need to be treated? 65
A modified Child-Turcotte-Pugh (CTP) for selection of candidates to liver transplantation (LT) with low model for end-stage liver disease score (MELD). 65
A modified Child-Turcotte-Pugh (CTP) for selection of patients affected by cirrhosis candidates for liver transplantation (LT) with low model for end-stage liver disease score (MELD) 64
Impact of exercise protocol on postural control in people with diabetes 60
Seven score systems to evaluate candidates to orthotopic liver transplantation: which is the winner? 60
The role of physical activity on autonomic functions in diabetic patients 59
Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes 59
Motor control evaluation in diabetic subjects 55
Natremia and Child-Turcotte-Pugh (CTP) score may improve the selection of candidates for liver transplantation (LT) with lower model for end-stage liver disease score (MELD) 54
Transition in inherited metabolic diseases: the dietitians, pediatricians and adult physicians’ point of view: the results of an Italian survey 51
Natremia and Child-Turcotte-Pugh (CTP) may improve the selection of candidates for liver transplantation (LT) with lower model for end-stage liver disease score (MELD). 48
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study 45
Lifetime physical activity and autonomic responses in adults with type 2 diabetes 43
NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders 18
NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders 15
null 1
Totale 10.860
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021105 0 0 0 0 0 0 0 0 0 0 0 105
2021/2022943 52 117 48 57 81 38 18 56 40 64 238 134
2022/20231.011 85 116 56 127 86 106 40 33 203 30 65 64
2023/2024463 42 69 33 43 35 83 14 48 18 39 13 26
2024/20251.966 77 230 172 190 254 71 117 74 52 151 146 432
2025/20265.518 446 499 483 466 483 243 638 202 988 422 434 214
Totale 10.860